Delivery Order SPE2DB25D3504-SPE2DB25FVTMV

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of atovaquone-proguanil 250-100 100s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $17,305.32 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 7, 2024. The award has an ultimate completion date of June 10, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $6,615.27 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, with a period of performance through November 2024. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Atovaquone-Proguanil 250-100 UD 24S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order worth $4,224.13, with a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,411.24 Firm Fixed Price Delivery Order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp's Corporate Office division. The $1,163.28 firm fixed-price delivery order is for the supply of 4,565,863,722 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The contract has an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,675.90 firm fixed-price delivery order is for the medical product "ATOVAQUONE-PROGUANIL 250-100 100S". The contract has an ultimate completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,491.40 Firm Fixed Price Delivery Order is for the supply of 4566428946 units of Atovaquone-Proguanil 250-100 mg tablets. The award has an ultimate completion date of November 15, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,795.26 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,231.23 Firm Fixed Price Delivery Order contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, with a period of performance through March 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation. The contract, valued at $27,358.06, is for the delivery of atovaquone-proguanil 250-100 100s, a pharmaceutical product used to prevent and treat malaria. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of October 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVTMV
    Delivery Order

This federal contract award is for the delivery of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,227.72 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 20, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.

Generated 5/22/25, 8:35 PM